New business is being written on visibly better terms than the company's own recent norm, and the mix shift has just beg
The model's full reasoning — Q2 2023 call → NOWe need to determine if management indicates that the economic terms of the newest business have stepped up meaningfully above the company's own recent norm, and that this improvement has only begun to flow into reported results because most of the business in the reported numbers was still written at older, less favorable terms. Let's analyze the transcript. The question is about economic terms: prices, rates, fees, spreads, contract sizes, durations, or profitability. The context is a spatial biology company selling instruments and reagents. The "economic terms" could refer to pricing of instruments, reagent pull-through (revenue per instrument), contract sizes, etc. Management discusses reagent pull-through: "annualized second quarter reagent pull-through has now increased to the mid-$30,000 range for both the PhenoCycler and HT as more PhenoCyclers paired with Fusion are up and running and as we see increasing utility of HT among biopharma and CROs, which are also our target customers for the recently launched PhenoCode signature panels. This is compared to an annualized pull-through per instrument in 2022 in the low $30,000 range for both the PhenoCycler and the PhenoImager HT." So pull-through increased from low $30k to mid $30k. That's an improvement in economics per instrument. But is that a "meaningful step up"? It's a modest increase. Also, they say "we anticipate annual reagent revenue growth to be in this range for the next several years." That suggests they expect continued growth. But the question specifically asks about "the economic terms of the company's newest business" — meaning the deals, orders, contracts, renewals, or transactions being struck now. The pull-through is a measure of reagent revenue per instrument, which reflects utilization and reagent consumption. It's not exactly pricing per unit, but it's a measure of revenue per instrument. However, the question is about "prices, rates, fees, spreads, contract sizes, durations, or profitability." Pull-through is a combination of volume and price. But management doesn't explicitly say they are raising prices or that new contracts are at better terms. They mention new product launches like signature panels and discovery panels, which might have higher ASPs. But they don't explicitly state that the terms of new business are meaningfully better than recent norm.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| CRBG | Corebridge Financial, Inc. | Q4 2022 | 2023-02-22 | B |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| INVH | Invitation Homes Inc. | Q2 2022 | 2022-07-28 | B+ |
| MTB | M&T Bank Corporation | Q2 2022 | 2022-07-20 | B+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| GNK | Genco Shipping & Trading Limited | Q2 2021 | 2021-08-07 | A |
| ESS | Essex Property Trust, Inc. | Q2 2018 | 2018-08-03 | B+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
CRL · Q2 2022 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management's comments on Safety Assessment pricing and backlog directly address both required elements: they describe current bookings and backlog at "escalating prices" and "meaningful price increases" that are already achieved on real transactions (not targets or future expectations), while noting that the reported Q2 results are still dominated by older 2022 terms and that the stronger pricing is accelerating into H2 and 2023 bookings.
ESS · Q2 2018 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...YES Management describes the loss-to-lease metric rising to 3.
CTO · Q2 2023 → YESThe question is about whether management indicates that the economic terms of the company's newest business have stepped up meaningfully above the company's own recent norm, and that this improvement ...